All my opinion...
Wednesday's annual report gets DRKOF to at least .75, if we don't hit that number before then. Then I'll say before the Q1 comes out in mid August, DRKOF gets its OTC status straightened out adding more intrigue, eyes and value to Martello from US investors who are currently hesitant to invest in a "grey" listed ticker...(hence the low volume).
Also before mid August, I suspect a clientele deal or two to get done, and maybe another acquisition, adding more value to the pps.
Then comes mid August, which Martello will release its 1st quarter numbers. That then leaves them with September and October to continue to add to their client base right before the Q2 numbers are released mid November.
If they CEO says his company is undervalued, I believe him...he sees the numbers firsthand.
At the moment, while Martello is just now being exposed, I'm kind of glad this is trading on the grey market, because only the brave will buy from the grey. Hopefully by the time DRKOF is QB or QX, the grey market will have yielded DRKOF a pps of well over a dollar. Then once a more comfortable crowd jumps in due to the OTC status update (and perhaps a ticker change), it's off to the races...but we will have the usual pull backs from profit takers.
So to reiterate...
Annual numbers on Wednesday, July 17th
Q1 numbers mid August
Q2 numbers mid November
In between those releases, there will be an OTC status update, along with deals and/or acquisitions, thus making Martello and its pps more valuable.
All just my opinion :)
